List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 21 studies with search of:   "Thymoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Condition: Thymoma and Thymic Carcinoma
Interventions: Drug: octreotide acetate;   Drug: prednisone
2 Recruiting Preoperative Treatment of Patients With High Risk Thymoma
Condition: Thymoma
Interventions: Drug: cisplatin and etoposide;   Procedure: Surgical Resection;   Radiation: Preoperative External Beam Radiotherapy
3 Recruiting Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Condition: Thymoma
Intervention: Drug: Octreotide
4 Active, not recruiting Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
Condition: Thymoma and Thymic Carcinoma
Interventions: Drug: carboplatin;   Drug: paclitaxel
5 Active, not recruiting Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Conditions: Thymoma;   Thymic Carcinoma
Intervention: Drug: Premetrexed (Alimta)
6 Completed A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Conditions: Thymic Cancer;   Thymoma
Interventions: Drug: bevacizumab;   Drug: Erlotinib
7 Recruiting AZD0530 in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
Condition: Thymoma and Thymic Carcinoma
Intervention: Drug: AZD0530
8 Recruiting Belinostat in Treating Patients With Recurrent or Metastatic Thymoma and Thymic Carcinoma That Cannot be Removed by Surgery
Condition: Thymoma and Thymic Carcinoma
Interventions: Drug: belinostat;   Procedure: DNA methylation analysis;   Procedure: flow cytometry;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis
9 Recruiting Paclitaxel and Cisplatin for Thymic Neoplasm
Conditions: Thymoma;   Thymic Carcinoma
Intervention: Drug: paclitaxel and cisplatin
10 Completed Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Conditions: Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer;   Thymoma and Thymic Carcinoma
Intervention: Drug: doxorubicin hydrochloride
11 Recruiting Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Colorectal Cancer;   Lung Cancer;   Malignant Mesothelioma;   Prostate Cancer;   Thymoma and Thymic Carcinoma
Intervention: Procedure: educational intervention
12 Active, not recruiting Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
Conditions: Graft Versus Host Disease;   Leukemia;   Myelodysplastic Syndromes;   Thymoma and Thymic Carcinoma
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: radiation therapy;   Procedure: umbilical cord blood transplantation
13 Active, not recruiting Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Conditions: Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer;   Thymoma and Thymic Carcinoma
Intervention: Procedure: radiofrequency ablation
14 Active, not recruiting Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: bone marrow ablation with stem cell support;   Procedure: radiation therapy;   Procedure: umbilical cord blood transplantation
15 Active, not recruiting Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
Condition: Thymic Carcinoma
Intervention: Drug: Gleevec (imatinib)
16 Recruiting Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: fentanyl sublingual spray;   Procedure: questionnaire administration
17 Completed MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: Cancer
Intervention: Drug: entinostat
18 Recruiting Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Condition: Myasthenia Gravis
Interventions: Procedure: thymectomy;   Drug: prednisone
19 Active, not recruiting Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Condition: Cancer
Intervention: Drug: recombinant adenovirus-hIFN-beta
20 Not yet recruiting Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Condition: Cancer
Interventions: Drug: hydroxychloroquine;   Drug: sunitinib malate

Previous Page Studies Shown (1-20) Next (21-21)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services